2024
CVCT Workshop
Future & Young Trialists
Patient trialists
iCVCT
Women as One
Archive
Â
CROs-AROs
Academics
Principal Investigators
Patients-
Advocacy
Regulatory
(FDA, EMA)
Industry R&D
Clinicians
Lawyers
Major journal editors
Statisticians-Methodologists
Payers-HTAs
MedTech-BioTech
Investors
Founder & chairman
UNIVERSITE DE LORRAINE, NANCY, FRA
See bio
Co-chairman
UNIVERSITY OF MICHIGAN, ANN ARBOR, USA
ULTIMATE DEEP DIVE IN MAJOR RECENT CLINICAL TRIALS
NEW AT CVCT 2024 : GOING GLOBAL
EXPANDING THE REACH OF THE FORUM TO INCLUDE UNDER-REPRESENTED “MOW” (MOST OF THE WORLD) TRIALISTS, FROM LATAM, AFRICA-ME, AND ASIA-PACIFIC IS CRUCIAL FOR FOSTERING DIVERSITY.
Beyond the occasional regional past CVCT meetings (CVCT Asia, and CVCT MEMA), this year, more work will be put into involving faculty members and regulators from these global regions.
THE LARGEST GLOBAL GATHERING OF CLINICAL TRIALS KEY STAKEHOLDERS! ​
BEYOND CARDIOLOGY, CVCT
AT THE INTERSECTION OF MULTIPLE CLINICAL SPECIALTIES
NEPHROLOGY, METABOLISM, ENDOCRINOLOGY, DIABETOLOGY, PULMONARY HYPERTENSION, LIPIDOLOGY
CARDIO-NEUROLOGY,
CARDIO-ONCOLOGY, RARE DISEASES, GERIATRY, PEDIATRIC CARDIOLOGY AND OTHERS…
ONLY THINK-TANK MULTISTAKEHOLDER BRAINSTORMING, NON-COMPETITIVE CASE STUDIES.
BUILDING BRIDGES​